CD34+ stem/progenitor cells
Ended Purchase Order Awarded Last action
- Contract number
- 75F40121P00531
- Awardee
-
Charles River Laboratories Cell Solutions, Inc. UEI NX7DKA7UH5M6
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $24,969
Award facts
- Contract value 100% obligated
- $24,969.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$31 | |
| Original award | $25,000 |
About this award
The Food and Drug Administration awarded a firm fixed-price purchase order to Charles River Laboratories Cell Solutions, Inc. for CD34+ stem/progenitor cells, with a ceiling value of $24,969.00. The contract, awarded on August 31, 2021, is scheduled for ultimate completion by March 12, 2026, and will be performed in Silver Spring, Maryland. No set-aside designation was applied to this award. This modification to the existing contract serves to de-obligate funds and close out the purchase order.
Charles River Laboratories Cell Solutions, Inc. is the sole prime contractor on this award, with no identified subcontractors noted. The FDA's procurement of CD34+ stem and progenitor cells supports the agency's regulatory and scientific operations, likely for research, testing, or standards development purposes related to cell therapies and regenerative medicine products under the FDA's jurisdiction. The relatively modest contract value reflects a specialized procurement for cellular materials rather than a large-scale supply or service engagement.
Quick answers
Who was awarded contract 75F40121P00531?
75F40121P00531 was awarded to Charles River Laboratories Cell Solutions, Inc. by Food and Drug Administration (Department of Health and Human Services) on August 31, 2021.
How much is contract 75F40121P00531 worth?
The government has obligated $24,969 on 75F40121P00531.
Was contract 75F40121P00531 competed?
The extent of competition for 75F40121P00531 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award